MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by Supertechon May 28, 2020 1:13pm

302 Views

Post# 31083478

Massive Sales Very Soon

The 3.5 million $ order was just an appetizer. We will have orders coming at us from every corner of the globe in the very near future. Medmira has the holy grail of test kits and soon every airport, sports facility, hospital, factory and anywhere else that will require fast accurate testing will be stocking up. Sales will be in the hundreds of millions if not billions. Biggest issue will be how to produce the kits fast enough to meet the astronomical demand.

Bullboard Posts

Changing Europe’s dependency on HREE from China